Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.

Abstract

BACKGROUND The clinical need to determine the presence of epidermal growth factor receptor (EGFR) gene mutations in non-small-cell lung cancers (NSCLC) in order to make informed decisions for patient treatment has seen the widespread introduction of EGFR molecular testing in many laboratories. To ensure high-quality molecular testing and allow laboratories… (More)
DOI: 10.1136/jclinpath-2012-201227

Topics

Cite this paper

@article{Deans2013ImprovementIT, title={Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.}, author={Zandra C. Deans and Neil Bilbe and Brendan O'Sullivan and Lazarus P. Lazarou and David Gonzalez de Castro and Suzanne C Parry and Andrew Dodson and Philippe Tani{\`e}re and Caroline Clark and Rachel Butler}, journal={Journal of clinical pathology}, year={2013}, volume={66 4}, pages={319-25} }